“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians.
Gespeichert in:
| Veröffentlicht in: | Cancer Immunology, Immunotherapy : CII Immunotherapy : CII, 2024-11, Vol.74 (1), p.19, Article 19 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 19 |
| container_title | Cancer Immunology, Immunotherapy : CII |
| container_volume | 74 |
| creator | Seliger, Barbara |
| description | The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians. |
| doi_str_mv | 10.1007/s00262-024-03877-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11561215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128817387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-bae6d00cdfc578dc10deed8374f4b58707e5a69f8ae04fa884de8ae1c042fc343</originalsourceid><addsrcrecordid>eNp9UUFuFDEQtBCIhMAHOCBLXIK0A217PPaeUIhCEikol-Vsee2eZaIZO9g7kfaWP3Aln8tLcHZCCBw4ue2uKld3EfKawXsGoD5kAN7wCnhdgdBKVewJ2WW1KE9asqeP6h3yIucLgJrDfP6c7Ii5FFI2apf0t9c_F-MQE-2GYQyxj6sNHRDXmcbgttfb6xu6vzj9cv5uRpmmB5epK6wfHKaS8mJgRrtAPyUbPIblmFbUBuox0RN7hf2MHmMabNi8JM9a22d8dX_uka-fjxaHJ9XZ-fHp4cFZ5YRs1tXSYuMBnG-dVNo7Bh7Ra6Hqtl5KrUChtM281Rahbq3WtcdSM1fma52oxR75OOlejssBvcOwTrY3xe1g08ZE25m_O6H7ZlbxyjAmG8aZLAr79wopfh8xr83QZYd9bwPGMRvBuNZMla0X6Nt_oBdxTKHMt0WBUEreCfIJ5VLMOWH74IaBuUvTTGmaskyzTdOwQnrzeI4Hyu_4CkBMgFxaYYXpz9__kf0FOVisLw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128037755</pqid></control><display><type>article</type><title>“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany</title><source>MEDLINE</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Seliger, Barbara</creator><creatorcontrib>Seliger, Barbara</creatorcontrib><description>The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians.</description><identifier>ISSN: 1432-0851</identifier><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-024-03877-1</identifier><identifier>PMID: 39535567</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Antibodies ; Antigens ; Artificial intelligence ; Cancer Research ; Cancer therapies ; Extracellular matrix ; Germany ; Humans ; Immunology ; Immunotherapy ; Immunotherapy - methods ; Leukemia ; Leukocytes ; Lymphocytes ; Medical Oncology - methods ; Medical prognosis ; Medical research ; Medicine ; Medicine & Public Health ; Meeting Report ; Myelodysplastic syndromes ; Neoplasms - immunology ; Neoplasms - therapy ; Neutrophils ; Oncology ; Pancreatic cancer ; Radiation ; Signal transduction ; Squamous cell carcinoma ; Stem cell transplantation ; T cell receptors ; Tumors</subject><ispartof>Cancer Immunology, Immunotherapy : CII, 2024-11, Vol.74 (1), p.19, Article 19</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561215/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561215/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,41118,41486,42187,42555,51317,51574,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39535567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seliger, Barbara</creatorcontrib><title>“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany</title><title>Cancer Immunology, Immunotherapy : CII</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><description>The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Artificial intelligence</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Extracellular matrix</subject><subject>Germany</subject><subject>Humans</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Immunotherapy - methods</subject><subject>Leukemia</subject><subject>Leukocytes</subject><subject>Lymphocytes</subject><subject>Medical Oncology - methods</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Meeting Report</subject><subject>Myelodysplastic syndromes</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>Neutrophils</subject><subject>Oncology</subject><subject>Pancreatic cancer</subject><subject>Radiation</subject><subject>Signal transduction</subject><subject>Squamous cell carcinoma</subject><subject>Stem cell transplantation</subject><subject>T cell receptors</subject><subject>Tumors</subject><issn>1432-0851</issn><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9UUFuFDEQtBCIhMAHOCBLXIK0A217PPaeUIhCEikol-Vsee2eZaIZO9g7kfaWP3Aln8tLcHZCCBw4ue2uKld3EfKawXsGoD5kAN7wCnhdgdBKVewJ2WW1KE9asqeP6h3yIucLgJrDfP6c7Ii5FFI2apf0t9c_F-MQE-2GYQyxj6sNHRDXmcbgttfb6xu6vzj9cv5uRpmmB5epK6wfHKaS8mJgRrtAPyUbPIblmFbUBuox0RN7hf2MHmMabNi8JM9a22d8dX_uka-fjxaHJ9XZ-fHp4cFZ5YRs1tXSYuMBnG-dVNo7Bh7Ra6Hqtl5KrUChtM281Rahbq3WtcdSM1fma52oxR75OOlejssBvcOwTrY3xe1g08ZE25m_O6H7ZlbxyjAmG8aZLAr79wopfh8xr83QZYd9bwPGMRvBuNZMla0X6Nt_oBdxTKHMt0WBUEreCfIJ5VLMOWH74IaBuUvTTGmaskyzTdOwQnrzeI4Hyu_4CkBMgFxaYYXpz9__kf0FOVisLw</recordid><startdate>20241113</startdate><enddate>20241113</enddate><creator>Seliger, Barbara</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20241113</creationdate><title>“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany</title><author>Seliger, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-bae6d00cdfc578dc10deed8374f4b58707e5a69f8ae04fa884de8ae1c042fc343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Artificial intelligence</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Extracellular matrix</topic><topic>Germany</topic><topic>Humans</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Immunotherapy - methods</topic><topic>Leukemia</topic><topic>Leukocytes</topic><topic>Lymphocytes</topic><topic>Medical Oncology - methods</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Meeting Report</topic><topic>Myelodysplastic syndromes</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>Neutrophils</topic><topic>Oncology</topic><topic>Pancreatic cancer</topic><topic>Radiation</topic><topic>Signal transduction</topic><topic>Squamous cell carcinoma</topic><topic>Stem cell transplantation</topic><topic>T cell receptors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seliger, Barbara</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy : CII</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seliger, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany</atitle><jtitle>Cancer Immunology, Immunotherapy : CII</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2024-11-13</date><risdate>2024</risdate><volume>74</volume><issue>1</issue><spage>19</spage><pages>19-</pages><artnum>19</artnum><issn>1432-0851</issn><issn>0340-7004</issn><eissn>1432-0851</eissn><abstract>The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39535567</pmid><doi>10.1007/s00262-024-03877-1</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1432-0851 |
| ispartof | Cancer Immunology, Immunotherapy : CII, 2024-11, Vol.74 (1), p.19, Article 19 |
| issn | 1432-0851 0340-7004 1432-0851 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11561215 |
| source | MEDLINE; Springer Nature OA Free Journals; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings |
| subjects | Animals Antibodies Antigens Artificial intelligence Cancer Research Cancer therapies Extracellular matrix Germany Humans Immunology Immunotherapy Immunotherapy - methods Leukemia Leukocytes Lymphocytes Medical Oncology - methods Medical prognosis Medical research Medicine Medicine & Public Health Meeting Report Myelodysplastic syndromes Neoplasms - immunology Neoplasms - therapy Neutrophils Oncology Pancreatic cancer Radiation Signal transduction Squamous cell carcinoma Stem cell transplantation T cell receptors Tumors |
| title | “Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A27%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CTumor%20immunology%20meets%20oncology%E2%80%9D%20(TIMO),%2018%20April%E2%80%9320%20April%202024,%20in%20Brandenburg%20an%20der%20Havel,%20Germany&rft.jtitle=Cancer%20Immunology,%20Immunotherapy%20:%20CII&rft.au=Seliger,%20Barbara&rft.date=2024-11-13&rft.volume=74&rft.issue=1&rft.spage=19&rft.pages=19-&rft.artnum=19&rft.issn=1432-0851&rft.eissn=1432-0851&rft_id=info:doi/10.1007/s00262-024-03877-1&rft_dat=%3Cproquest_pubme%3E3128817387%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128037755&rft_id=info:pmid/39535567&rfr_iscdi=true |